Form S-1 Aptevo Therapeutics Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Aptevo Therapeutics files prospectus for resale of 6.4M shares
August 21, 2026 4:13 PM EDTAptevo Therapeutics Inc. (NASDAQ: APVO) filed a prospectus related to the potential resale of up to 6,444,858 shares of common stock, par value $0.001 per share, by certain selling stockholders.
The shares are issuable upon the exercise of three types of warrants: pre-funded common stock... More
